Published in Transl Oncol on February 01, 2014
Radiomics: Images Are More than Pictures, They Are Data. Radiology (2015) 1.68
Classifying the evolutionary and ecological features of neoplasms. Nat Rev Cancer (2017) 1.07
Evolutionary triage governs fitness in driver and passenger mutations and suggests targeting never mutations. Nat Commun (2014) 0.97
Evaluation of tumor-derived MRI-texture features for discrimination of molecular subtypes and prediction of 12-month survival status in glioblastoma. Med Phys (2015) 0.97
Combining radiomic features with a miRNA classifier may improve prediction of malignant pathology for pancreatic intraductal papillary mucinous neoplasms. Oncotarget (2016) 0.93
Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques. Neuro Oncol (2015) 0.89
Prognostic Imaging Biomarkers in Glioblastoma: Development and Independent Validation on the Basis of Multiregion and Quantitative Analysis of MR Images. Radiology (2015) 0.84
Darwinian Dynamics of Intratumoral Heterogeneity: Not Solely Random Mutations but Also Variable Environmental Selection Forces. Cancer Res (2016) 0.84
Heterogeneity in intratumoral regions with rapid gadolinium washout correlates with estrogen receptor status and nodal metastasis. J Magn Reson Imaging (2015) 0.83
Can oncology recapitulate paleontology? Lessons from species extinctions. Nat Rev Clin Oncol (2015) 0.82
Magnetic Resonance Imaging-Based Radiomic Profiles Predict Patient Prognosis in Newly Diagnosed Glioblastoma Before Therapy. Tomography (2016) 0.79
Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies. Oncotarget (2016) 0.78
Combining Radiation Therapy with Immune Checkpoint Blockade for Central Nervous System Malignancies. Front Oncol (2016) 0.78
Radiomic features from the peritumoral brain parenchyma on treatment-naïve multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: Preliminary findings. Eur Radiol (2016) 0.78
Radiogenomic Analysis of Oncological Data: A Technical Survey. Int J Mol Sci (2017) 0.77
Associating spatial diversity features of radiologically defined tumor habitats with epidermal growth factor receptor driver status and 12-month survival in glioblastoma: methods and preliminary investigation. J Med Imaging (Bellingham) (2015) 0.75
Spatial Habitat Features Derived from Multiparametric Magnetic Resonance Imaging Data Are Associated with Molecular Subtype and 12-Month Survival Status in Glioblastoma Multiforme. PLoS One (2015) 0.75
Investigating intracranial tumour growth patterns with multiparametric MRI incorporating Gd-DTPA and USPIO-enhanced imaging. NMR Biomed (2016) 0.75
Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature (2008) 75.40
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med (2012) 44.56
The clonal evolution of tumor cell populations. Science (1976) 24.39
Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature (2010) 17.38
Clonal evolution in cancer. Nature (2012) 11.07
Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer (2012) 6.82
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci U S A (2013) 5.68
A microenvironmental model of carcinogenesis. Nat Rev Cancer (2008) 4.40
How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine. Br J Cancer (2010) 4.19
Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. Proc Natl Acad Sci U S A (2008) 4.14
Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. Genes Dev (2010) 3.99
Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer. J Nucl Med (2011) 3.66
Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer (2012) 3.56
Preparing for precision medicine. N Engl J Med (2012) 3.34
Decoding global gene expression programs in liver cancer by noninvasive imaging. Nat Biotechnol (2007) 3.17
Evolutionary dynamics of carcinogenesis and why targeted therapy does not work. Nat Rev Cancer (2012) 2.71
A brain tumor segmentation framework based on outlier detection. Med Image Anal (2004) 2.62
Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanoma. PLoS One (2012) 2.40
Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme. PLoS One (2011) 2.35
Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival. Eur Radiol (2011) 2.16
Automatic tumor segmentation using knowledge-based techniques. IEEE Trans Med Imaging (1998) 1.90
Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis. Eur J Nucl Med Mol Imaging (2012) 1.75
Why your new cancer biomarker may never work: recurrent patterns and remarkable diversity in biomarker failures. Cancer Res (2012) 1.69
Quantitative imaging in cancer evolution and ecology. Radiology (2013) 1.55
Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging. Neuro Oncol (2012) 1.38
Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging. Radiology (2010) 1.28
Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer. Cancer Res (2012) 1.28
The basis for current treatment recommendations for malignant gliomas. J Neurooncol (1994) 1.25
Quantifying heterogeneity in human tumours using MRI and PET. Eur J Cancer (2012) 1.20
Long-term survivors of glioblastoma: clinical features and molecular analysis. Acta Neurochir (Wien) (2009) 1.08
Evaluating intensity normalization on MRIs of human brain with multiple sclerosis. Med Image Anal (2010) 0.96
MR imaging of the musculoskeletal soft tissue mass: is heterogeneity a sign of malignancy? J Chin Med Assoc (2003) 0.92